Status:
COMPLETED
Optimizing the Use of Entonox® During Screening Colonoscopy
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Bowel Cancer Screening
Analgesia
Eligibility:
All Genders
60-75 years
Phase:
PHASE4
Brief Summary
This study will randomise patients undergoing screening colonoscopy to receive Entonox either continuously or as required. Both these methods are used in the published studies of Entonox and in clini...
Eligibility Criteria
Inclusion
- Having a bowel cancer screening programme colonoscopy
Exclusion
- Contraindications to Entonox
- Previous bowel resections
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01865721
Start Date
January 1 2013
End Date
April 1 2014
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, South Yorkshire, United Kingdom, S5 7AU